| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2021-03-01 | |
| P1050 | medical condition | polycythemia | Q933716 |
| | polycythemia vera | Q948318 |
| | chronic idiopathic myelofibrosis | Q3857106 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 24 | |
| P6153 | research site | Icahn School of Medicine at Mount Sinai | Q1950740 |
| P859 | sponsor | Icahn School of Medicine at Mount Sinai | Q1950740 |
| P580 | start time | 2019-02-15 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase I Study of AVID200 in Patients With Myelofibrosis (Myeloproliferative Neoplasms Research Consortium [MPN-RC] 118) | |